These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 16527086)
1. [Pharmacogenetics in the treatment of asthma]. Tellería Orriols JJ; Blanco Quirós A An Pediatr (Barc); 2006 Mar; 64(3):221-3. PubMed ID: 16527086 [No Abstract] [Full Text] [Related]
2. Pharmacogenetics of asthma. Palmer LJ; Silverman ES; Weiss ST; Drazen JM Am J Respir Crit Care Med; 2002 Apr; 165(7):861-6. PubMed ID: 11934710 [No Abstract] [Full Text] [Related]
3. How pharmacogenomics will play a role in the management of asthma. Wechsler ME; Israel E Am J Respir Crit Care Med; 2005 Jul; 172(1):12-8. PubMed ID: 15778484 [No Abstract] [Full Text] [Related]
4. Pharmacogenetics of asthma. Hall IP Chest; 2006 Dec; 130(6):1873-8. PubMed ID: 17167011 [TBL] [Abstract][Full Text] [Related]
6. Genetics and the variability of treatment response in asthma. Israel E J Allergy Clin Immunol; 2005 Apr; 115(4 Suppl):S532-8. PubMed ID: 15806036 [TBL] [Abstract][Full Text] [Related]
7. Personalized medicine for patients with asthma. Greenberger PA J Allergy Clin Immunol; 2010 Feb; 125(2):305-6. PubMed ID: 20159238 [No Abstract] [Full Text] [Related]
8. Personalised prescribing for asthma--is pharmacogenetics the answer? Dewar JC; Hall IP J Pharm Pharmacol; 2003 Mar; 55(3):279-89. PubMed ID: 12724032 [TBL] [Abstract][Full Text] [Related]
9. Overview of the pharmacogenetics of asthma treatment. Weiss ST; Litonjua AA; Lange C; Lazarus R; Liggett SB; Bleecker ER; Tantisira KG Pharmacogenomics J; 2006; 6(5):311-26. PubMed ID: 16568148 [TBL] [Abstract][Full Text] [Related]
10. Genetic basis for personalized medicine in asthma. Portelli M; Sayers I Expert Rev Respir Med; 2012 Apr; 6(2):223-36. PubMed ID: 22455494 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic and pharmacogenomic considerations of asthma treatment. Matera MG; Rinaldi B; Calzetta L; Cazzola M Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1159-1167. PubMed ID: 28992739 [TBL] [Abstract][Full Text] [Related]
12. Managing asthma in the 21st century: role of pharmacogenetics. Wechsler ME Pediatr Ann; 2006 Sep; 35(9):660-2, 664-9. PubMed ID: 16999299 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort. Koster ES; Raaijmakers JA; Koppelman GH; Postma DS; van der Ent CK; Koenderman L; Bracke M; Maitland-van der Zee AH Pharmacogenomics; 2009 Aug; 10(8):1351-61. PubMed ID: 19663678 [TBL] [Abstract][Full Text] [Related]
18. [PHARMACOGENETIC MARKERS OF THE EFFECTIVENESS OF TREATMENT OF CHILDREN WITH ATOPIC BRONCHIAL ASTHMA.]. Balabolkin II; Bulgakova VA Eksp Klin Farmakol; 2016; 79(11):35-40. PubMed ID: 29791107 [TBL] [Abstract][Full Text] [Related]
19. The role of pharmacogenomics in improving the management of asthma. Kazani S; Wechsler ME; Israel E J Allergy Clin Immunol; 2010 Feb; 125(2):295-302; quiz 303-4. PubMed ID: 20159237 [TBL] [Abstract][Full Text] [Related]
20. Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone. Stockmann C; Reilly CA; Fassl B; Gaedigk R; Nkoy F; Stone B; Roberts JK; Uchida DA; Leeder JS; Sherwin CM; Spigarelli MG; Yost GS; Ward RM J Allergy Clin Immunol; 2015 Aug; 136(2):505-7. PubMed ID: 25825214 [No Abstract] [Full Text] [Related] [Next] [New Search]